Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSLPE.L Regulatory News (SLPE)

  • There is currently no data for SLPE

Quarterly Trading Statement

24 Mar 2016 14:00

RNS Number : 2386T
Standard Life Euro Pri Eqty Tst PLC
24 March 2016
Β 

Standard Life European Private Equity Trust PLC

Β 

1. Investment update for the quarter from 1 October to 31 December 2015

Β 

Β· NAV increased 3.5% to 291.5p for the quarter ended 31 December 2015

Β· Realised gains and income were Β£24.0 million (6.5% of opening portfolio valuation). The unrealised losses on the portfolio on a constant exchange rate basis were Β£11.1 million (3.0% of opening portfolio valuation); in addition, there were unrealised foreign exchange gains on the portfolio of Β£1.1 million (0.3% of opening portfolio valuation)

Β· 100.0% by value of the portfolio was valued by the respective underlying managers at 31 December 2015

Β· Outstanding commitments were Β£240.0 million at 31 December 2015

Β· Cash balance was Β£40.5 million and Β£39.3 million was invested in equity index tracker funds at 31 December 2015

Β 

For the quarter ended 31 December 2015 the Company's net asset value per ordinary share ("NAV") increased by 3.5% to 291.5p, from 281.6p at 30 September 2015. At 31 December 2015 the Company's net assets were Β£454.1 million (30 September 2015 - Β£438.7 million).

Β 

In light of the volatile listed financial markets and a weakening global macro-economic environment, the quarter ended 31 December 2015 saw a decrease in new investment activity in the European private equity market. The value of all new private equity transactions in the European private equity market announced during the quarter was €35.8 billion (quarter ended 30 September 2015 - €40.5 billion), of which €29.4 billion comprised buy-out transactions (quarter ended 30 September 2015 - €34.2 billion).

Β 

Distributions received by the Company during the quarter ended 31 December 2015 were Β£45.1 million (quarter ended 30 September 2015 - Β£34.6 million) and the Company funded Β£17.0 million of draw downs (quarter ended 30 September 2015 - Β£12.0 million). The distributions received by the Company generated net realised gains and income of Β£24.0 million, which was equivalent to a return of 2.1Β times the acquisition cost of the realised investments.

Β 

The closing value of the Company's portfolio of 47 private equity fund interests was Β£373.9 million at 31 December 2015 (30 September 2015 - 46 fund interests and Β£369.0 million). Total net unrealised losses on the portfolio for the quarter were Β£10.0 million, of which Β£11.1 million were net unrealised losses on a constant exchange rate basis and Β£1.1 million were net unrealised foreign exchange gains. During the quarter ended 31 December 2015, sterling was flat against the euro and depreciated by 2.7% against the US dollar.

Β 

In line with the Company's investment strategy, the Company acquired through a secondary purchase an original commitment of $60.0 million to TowerBrook Investors III in December 2015.Β The purchase price for the fund interest was Β£19.1 million, equivalent to a discount of 6.1% to the most recent valuation at 30 September 2015, adjusted for subsequent cashflows. The Company assumed outstanding commitments of Β£10.8 million on acquisition. The Company does not have an existing commitment to TowerBrook Investors III, but has existing commitments of $25.0 million and $35.0 million to TowerBrook Investors II and IV respectively.

Β 

At 31 December 2015 the Company had a cash balance of Β£40.5 million and had Β£39.3 million invested at value (Β£39.2 million at cost) in UK and European equity index tracker funds. The Company has an undrawn Β£80 million syndicated revolving credit facility, provided by Citi and Societe Generale, that expires in December 2020.

Β 

At 31 December 2015 the Company had total outstanding commitments of Β£240.0 million to 47 private equity fund interests (30 September 2015 - Β£245.8 million and 46 fund interests). After undertaking a detailed review, the Manager now believes that up to Β£55 million of the Company's existing outstanding commitments are unlikely to be drawn (30 September 2015 - Β£50 million).

Β 

2. Events and transactions since 1 January 2016

Β 

During the period from 1 January to 23 March 2016 the Company received Β£29.2 million of distributions and funded Β£16.0 million of draw downs.

Β 

A new commitment of €45.0 million was made to Advent International GPE VIII in February 2016. At 23 March 2016 the Company had total outstanding commitments of Β£271.4 million.

Β 

On 29 January 2016 the Company paid a final dividend for the year ended 30 September 2015 of 3.5p per ordinary share (total for the year of 5.25 pence per share). The cost of the final dividend was Β£5.5 million.

Β 

At 23 March 2016 the Company had a cash balance of Β£50.1 million and had Β£39.7 million invested at value (Β£39.2 million at cost) in UK and European equity index tracker funds.

Β 

The Company's estimated NAV at 29 February 2016 is also being announced today. It is anticipated that the Company will release its interim announcement for the six months ending 31 March 2016 on 27 May 2016.

Β 

For further information please contact:-

Β 

Peter McKellar or Roger Pim at SL Capital Partners LLP (0131 245 0055)

Β 

Note:-

Standard Life European Private Equity Trust PLC is an investment company managed by SL Capital Partners LLP, the ordinary shares of which are admitted to listing by the UK Listing Authority and to trading on the Stock Exchange and which seeks to conduct its affairs so as to qualify as an investment trust under section 1158 of the Corporation Tax Act 2010. The Board of Standard Life European Private Equity Trust PLC is independent of Standard Life plc.

Β 

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
MSCXZLFLQXFXBBL
Date   Source Headline
16th Mar 20117:30 amRNSQuarterly Trading Statement
31st Jan 20113:54 pmRNSDirector/PDMR Shareholding
31st Jan 20113:53 pmRNSDirector/PDMR Shareholding
31st Jan 201111:50 amRNSTotal Voting Rights
31st Jan 201111:03 amRNSDirector/PDMR Shareholding
27th Jan 201111:03 amRNSAnnual Financial Report
26th Jan 20119:33 amRNSIssue of Equity
25th Jan 20114:08 pmRNSResult of AGM
25th Jan 20111:00 pmRNSInterim Management Statement
17th Jan 201111:28 amRNSDirector/PDMR Shareholding
6th Jan 20112:05 pmRNSCalculation of Script Dividend Reference Price
6th Jan 201111:28 amRNSQuarterly Disclosure
21st Dec 201011:07 amRNSDoc re. Annual Report
20th Dec 20104:26 pmRNSAnnual Information Update
8th Dec 20104:02 pmRNSDirector/PDMR Shareholding
6th Dec 20107:00 amRNSPreliminary Results for year to 30/09/10
2nd Dec 20102:30 pmRNSDirectorate Change
30th Nov 20107:00 amRNSRefinancing of debt facility
17th Nov 20109:20 amRNSDirector Declaration
4th Oct 20102:45 pmRNSQuarterly Disclosure
30th Sep 20105:30 pmRNSTotal Voting Rights
28th Sep 201010:46 amRNSApplication for Listing
22nd Sep 20107:00 amRNSInvestment update for quarter to 30 June 2010
10th Aug 201012:49 pmRNSInterim Management Statement
2nd Jun 201012:36 pmRNSHolding(s) in Company
28th May 20107:00 amRNSHalf Yearly Report
9th Apr 201012:46 pmRNSHolding(s) in Company
17th Mar 20107:00 amRNSTrading Statement
9th Feb 201011:40 amRNSDirector/PDMR Shareholding
8th Feb 201010:19 amRNSDirector/PDMR Shareholding
2nd Feb 20103:02 pmRNSDirector/PDMR Shareholding
1st Feb 201011:14 amRNSDirector/PDMR Shareholding
1st Feb 201011:12 amRNSDirector/PDMR Shareholding
1st Feb 201011:10 amRNSDirector/PDMR Shareholding
1st Feb 201011:06 amRNSTotal Voting Rights
27th Jan 20103:39 pmRNSResult of AGM
27th Jan 201012:13 pmRNSInterim Management Statement
27th Jan 201010:00 amRNSApplication for Listing
20th Jan 20109:47 amRNSHolding(s) in Company
14th Jan 201011:30 amRNSAnnual Financial Report
12th Jan 201010:39 amRNSAnnual Information Update
7th Jan 20104:41 pmRNSCalculation of scrip dividend reference price
5th Jan 201012:46 pmRNSQuarterly Disclosure
23rd Dec 200910:57 amRNSDirector/PDMR Shareholding - Replacement
17th Dec 20092:25 pmRNSDoc re. Annual Report and Circular
3rd Dec 200912:13 pmRNSDirector/PDMR Shareholding
3rd Dec 20097:00 amRNSPreliminary results for year to 30/9/09
18th Sep 20097:00 amRNSThird Quarter Trading Statement
29th Jul 20097:30 amRNSInterim Management Statement
8th Jul 20092:23 pmRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.